Cytek Biosciences Inc.

NASDAQ: CTKB · Real-Time Price · USD
3.71
-0.04 (-1.07%)
At close: Apr 30, 2025, 3:59 PM
3.71
0.00%
After-hours: Apr 30, 2025, 04:22 PM EDT
-1.07%
Bid 3.69
Market Cap 475.24M
Revenue (ttm) 176.63M
Net Income (ttm) -6.02M
EPS (ttm) -0.05
PE Ratio (ttm) -74.2
Forward PE 77.3
Analyst Buy
Ask 4.05
Volume 283,312
Avg. Volume (20D) 839,975
Open 3.68
Previous Close 3.75
Day's Range 3.62 - 3.75
52-Week Range 3.27 - 7.63
Beta 1.41

About CTKB

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full sp...

Sector Healthcare
IPO Date Jul 23, 2021
Employees 648
Stock Exchange NASDAQ
Ticker Symbol CTKB
Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for CTKB stock is "Buy." The 12-month stock price forecast is $7, which is an increase of 88.68% from the latest price.

Stock Forecasts

Next Earnings Release

Cytek Biosciences Inc. is scheduled to release its earnings on May 8, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-6.65%
Cytek Biosciences shares are trading lower after t... Unlock content with Pro Subscription
5 months ago
+36.03%
Cytek Biosciences shares are trading higher after the company reported better-than-expected Q3 financial results.